Literature DB >> 20411584

Structural elucidation of N-oxidized clemastine metabolites by liquid chromatography/tandem mass spectrometry and the use of Cunninghamella elegans to facilitate drug metabolite identification.

Annica Tevell Aberg1, Helena Löfgren, Ulf Bondesson, Mikael Hedeland.   

Abstract

Cunninghamella elegans is a filamentous fungus that has been shown to biotransform drugs into the same metabolites as mammals. In this paper we describe the use of C. elegans to aid the identification of clemastine metabolites since high concentrations of the metabolites were produced and MS(n) experiments were facilitated. The combination of liquid chromatography and tandem mass spectrometry with two different ionization techniques and hydrogen/deuterium exchange were used for structural elucidation of the clemastine metabolites. Norclemastine, four isomers of hydroxylated clemastine, and two N-oxide metabolites were described for the first time in C. elegans incubations. The N-oxidations were confirmed by hydrogen/deuterium exchange and deoxygenation (-16 Da) upon atmospheric pressure chemical ionization mass spectrometry. By MS(n) fragmentation it was concluded that two of the hydroxylated metabolites were oxidized on the methylpyrridyl moiety, one on the aromatic ring with the chloro substituent, and one on the aromatic ring without the chlorine. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411584     DOI: 10.1002/rcm.4535

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  4 in total

1.  Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.

Authors:  Keith K Burkhart; Darrell Abernethy; David Jackson
Journal:  J Med Toxicol       Date:  2015-06

2.  Biotransformation of bromhexine by Cunninghamella elegans, C. echinulata and C. blakesleeana.

Authors:  Aman K Dube; Maushmi S Kumar
Journal:  Braz J Microbiol       Date:  2016-12-05       Impact factor: 2.476

3.  Investigation of Equine In Vivo and In Vitro Derived Metabolites of the Selective Androgen Receptor Modulator (SARM) ACP-105 for Improved Doping Control.

Authors:  Malin Nilsson Broberg; Heather Knych; Ulf Bondesson; Curt Pettersson; Scott Stanley; Mario Thevis; Mikael Hedeland
Journal:  Metabolites       Date:  2021-02-01

4.  Drug absorption efficiency in Caenorhbditis elegans delivered by different methods.

Authors:  Shan-Qing Zheng; Ai-Jun Ding; Guo-Ping Li; Gui-Sheng Wu; Huai-Rong Luo
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.